Skip to main content

Table 2 Baseline, 12 and 24 week scores: values are mean (SD) unless stated otherwise

From: Clinical effectiveness of a web-based peer-supported self-management intervention for relatives of people with psychosis or bipolar (REACT): online, observer-blind, randomised controlled superiority trial

 

REACT

RD

Total

GHQ-28

 Baseline

40.3 (14.6)

40.0 (14.0)

40.2 (14.3)

 12 weeks

30.6 (15.2)

32.9 (15.4)

31.8 (15.3)

 24 weeks

29.6 (15.9)

31.3 (15.2)

30.5 (15.6)

GHQ-28 subscales

 Somatic symptoms

  Baseline

10.3 (4.4)

10.4 (4.0)

10.3 (4.2)

  12 weeks

8.1 (4.3)

8.7 (4.4)

8.4 (4.4)

  24 weeks

7.9 (4.7)

8.3 (4.5)

8.1 (4.6)

 Anxiety/insomnia

  Baseline

13.0 (4.1)

12.9 (4.0)

13.0 (4.1)

  12 weeks

9.5 (4.7)

10.1 (4.8)

9.8 (4.7)

  24 weeks

9.2 (4.9)

9.9 (4.9)

9.6 (4.9)

 Social dysfunction: note that values are median (IQR)

  Baseline

11 (8–13)

11 (8–14)

11 (8–13.5)

  12 weeks

8 (7–11)

9 (7–13)

9 (7–12)

  24 weeks

8 (7–11)

8 (7–11)

8 (7–11)

 Severe depression: note that values are median (IQR)

  Baseline

4 (1–9)

4 (1–9)

4 (1–9)

  12 weeks

2 (0–7)

3 (0–7)

2 (0–7)

  24 weeks

2 (0–6)

2 (0–7)

2 (0–7)

CWS - wellbeing

 Baseline

55.9 (25.9)

55.8 (26.4)

55.9 (26.1)

 12 weeks

72.0 (27.0)

68.9 (27.7)

70.3 (27.4)

 24 weeks

77.0 (26.6)

72.6 (30.5)

74.7 (28.8)

CWS - support

 Baseline

19.5 (11.6)

18.8 (11.7)

19.1 (11.7)

 12 weeks

26.0 (12.0)

22.6 (12.0)

24.2 (12.1)

 24 weeks

25.7 (11.7)

23.2 (12.2)

24.4 (12.0)